Literature DB >> 25992695

Submandibular gland excision.

Alexandre Sanfurgo de Carvalho1, Rogério Aparecido Dedivitis2, Mario Augusto Ferrari de Castro3, Carlos Eduardo Molinari Nardi1.   

Abstract

OBJECTIVE: to analyze the value of fine needle aspiration and the rates of postoperative complications in patients undergoing resection of the submandibular gland.
METHODS: we analyzed the records of patients treated with resection of the gland from January 1995 to December 2008. The data collected included age, gender, findings on clinical history, surgical procedure, results of fine needle aspiration (FNA), pathological diagnosis and complications.
RESULTS: 117 patients were studied, aged 12-89 years (mean 48), 70 women and 47 men. Thirty-nine patients (33.3%) were affected by inflammatory diseases (28 patients with lithiasis), 70 had benign tumors, and malignant tumors, eight. Regarding FNA, the sensitivity and specificity were 85.7% and 100%, respectively. Nine patients (7.7%) had temporary paralysis of the marginal mandibular nerve and one had permanent paralysis.
CONCLUSION: resection of the submandibular gland is a safe procedure, with low complication rates.

Entities:  

Mesh:

Year:  2015        PMID: 25992695     DOI: 10.1590/0100-69912015001004

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  3 in total

1.  3D Reconstruction and Prediction of Sialolith Surgery.

Authors:  Jamyson Oliveira Santos; Brunna da Silva Firmino; Matheus Santos Carvalho; Jean de Pinho Mendes; Lucas Novaes Teixeira; Sérgio Lúcio Pereira de Castro Lopes; André Luiz Ferreira Costa; Antonione Santos Bezerra Pinto
Journal:  Case Rep Dent       Date:  2018-11-13

2.  Recurrent Submandibular Sialolithiasis in a Child.

Authors:  How Kit Thong; Hafiz Mohamad Mahbob; Primuharsa Putra Sabir Husin Athar; Tengku Mohamed Izam Tengku Kamalden
Journal:  Cureus       Date:  2020-12-19

Review 3.  Complications of traditional and modern therapeutic salivary approaches.

Authors:  O Nahlieli
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.